Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation (2024)

Choose the Right Test

ARUP Consult® assists with test selection and interpretation

Go to ARUP Consult

Example Reports

Patient PreparationInstructions patient must follow before/during specimen collection.

CollectSpecimen type to collect. May include collection media, tubes, kits, etc.

Random urine.

Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.

Transfer 8 mL urine with no additives or preservatives to ARUP Standard Transport Tubes. (Min: 4 mL)

Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.

Refrigerated.

Unacceptable ConditionsCommon conditions under which a specimen will be rejected.

Specimens exposed to repeated freeze/thaw cycles.

RemarksAdditional specimen collection, transport, or test submission information.

StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.

Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month

Qualitative Enzyme Multiplied Immunoassay Technique (EMIT)/Quantitative Gas Chromatography-Mass Spectrometry (GC-MS)/Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Sun-Sat

1-4 days

The absence of expected drug(s) and/or drug metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results. The following opioids are not detected in this test: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to aruplab.com for test information.

For medical purposes only; not valid for forensic use.

If the specimen screens positive, then Confirmation/Quantitation by GC/MS and/or LC-MS/MS will be added to confirm result. Additional charges apply.

To order testing for individual opioids, refer to Fentanyl and Metabolite-Confirmation/Quantitation-Urine (ARUP test code 0092570), Buprenorphine and Metabolites-Confirmation/Quantitation-Urine (ARUP test code 2010092), Meperidine and Metabolite Quantitative, Urine (ARUP test code 3000248), Tramadol and Metabolites-Confirmation/Quantitation-Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).

CPT Codes

The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually.
CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ.
CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.